Platelet-activating factor enhances tumour metastasis via the reactive oxygen species-dependent protein kinase casein kinase 2-mediated nuclear factor-κB activation

Immunology

Volumn 143, Issue 1, 2014, Pages 21-32

  Kim, Kyoung Jin ^a   Cho, Kyung Deuk ^a   Jang, Kyu Yun ^b   Kim, Han A ^a,c   Kim, Hae Kyoung ^b   Lee, Hern Ku ^b   Im, Suhn Young ^a  

^a Chonnam National University   (South Korea)

^b Chonbuk National University Medical School   (South Korea)

^c Gwangju Institute of Science and Technology (GIST)   (South Korea)

Author keywords

Casein kinase 2; Nuclear factor B; Platelet activating factor; Reactive oxygen species; Tumour metastasis

Indexed keywords

ACETYLCYSTEINE; CASEIN KINASE II; CYTOKINE; HYDROGEN PEROXIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE P38; MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR; REACTIVE OXYGEN METABOLITE; THROMBOCYTE ACTIVATING FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; IN VITRO STUDY; IN VIVO STUDY; LUNG METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

CASEIN KINASE 2; NUCLEAR FACTOR-ΚB; PLATELET-ACTIVATING FACTOR; REACTIVE OXYGEN SPECIES; TUMOUR METASTASIS;

ANIMALS; BLOTTING, WESTERN; CASEIN KINASE II; DISEASE MODELS, ANIMAL; ELECTROPHORETIC MOBILITY SHIFT ASSAY; ENZYME ACTIVATION; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MICE; MICE, INBRED C57BL; NEOPLASM INVASIVENESS; NF-KAPPA B; PLATELET ACTIVATING FACTOR; REACTIVE OXYGEN SPECIES; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84904873209     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/imm.12283     Document Type: Article

References (49)

1. Coussens LM, Werb Z. Inflammation and cancer. Nature 2002; 420:860-7.
2. Marx J. Cancer research. Inflammation and cancer: the link grows stronger. Science 2004; 306:966-8.
3. Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet 2001; 357:539-45.
4. Condeelis J, Pollard JW. Macrophages: obligate partners for tumor cell migration, invasion, and metastasis. Cell 2006; 124:263-6.
5. Egeblad M, Littlepage LE, Werb Z. The fibroblastic coconspirator in cancer progression. Cold Spring Harb Symp Quant Biol 2005; 70:383-8.
6. Egeblad M, Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2002; 2:161-74.
7. Zlotnik A. Chemokines and cancer. Int J Cancer 2006; 119:2026-9.
8. Karin M, Greten FR. NF-κB: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol 2005; 5:749-59.
9. Gay JC. Mechanism and regulation of neutrophil priming by platelet-activating factor. J Cell Physiol 1993; 156:189-97.
10. Shukla SD. Platelet-activating factor receptor and signal transduction mechanisms. FASEB J 1992; 6:2296-301.
11. Braquet P, Touqui L, Shen TY, Vargaftig BB. Perspectives in platelet-activating factor research. Pharmacol Rev 1987; 39:97-145.
12. Im SY, Ko HM, Kim JW et al. Augmentation of tumor metastasis by platelet-activating factor. Cancer Res 1996; 56:2662-5.
13. Im SY, Han SJ, Ko HM, Choi JH, Chun SB, Lee DG, Ha TY, Lee HK. Involvement of nuclear factor-κB in platelet-activating factor-mediated tumor necrosis factor-α expression. Eur J Immunol 1997; 27:2800-4.
14. Choi JH, Ko HM, Kim JW, Lee HK, Han SS, Chun SB, Im SY. Platelet-activating factor-induced early activation of NF-κB plays a crucial role for organ clearance of Candida albicans. J Immunol 2001; 166:5139-44.
15. Borthakur A, Bhattacharyya S, Alrefai WA, Tobacman JK, Ramaswamy K, Dudeja PK. Platelet-activating factor-induced NF-κB activation and IL-8 production in intestinal epithelial cells are Bcl10-dependent. Inflamm Bowel Dis 2010; 16:593-603.
16. Borthakur A, Bhattacharyya S, Kumar A, Anbazhagan AN, Tobacman JK, Dudeja PK. Lactobacillus acidophilus alleviates platelet-activating factor-induced inflammatory responses in human intestinal epithelial cells. PLoS One 2013; 8:e75664.
17. Ko HM, Seo KH, Han SJ et al. Nuclear factor κB dependency of platelet-activating factor-induced angiogenesis. Cancer Res 2002; 62:1809-14.
18. Seo KH, Ko HM, Choi JH, Jung HH, Chun YH, Choi IW, Lee HK, Im SY. Essential role for platelet-activating factor-induced NF-κB activation in macrophage-derived angiogenesis. Eur J Immunol 2004; 34:2129-37.
19. Ko HM, Park YM, Jung B, Kim HA, Choi JH, Park SJ, Lee HK, Im SY. Involvement of matrix metalloproteinase-9 in platelet-activating factor-induced angiogenesis. FEBS Lett 2005; 579:2369-75.
20. Heon Seo K, Ko HM, Kim HA, Choi JH, Jun Park S, Kim KJ, Lee HK, Im SY. Platelet-activating factor induces up-regulation of antiapoptotic factors in a melanoma cell line through nuclear factor-κB activation. Cancer Res 2006; 66:4681-6.
21. Litchfield DW. Protein kinase CK2: structure, regulation and role in cellular decisions of life and death. Biochem J 2003; 369:1-15.
22. Duncan JS, Litchfield DW. Too much of a good thing: the role of protein kinase CK2 in tumorigenesis and prospects for therapeutic inhibition of CK2. Biochim Biophys Acta 2008; 1784:33-47.
23. Singh NN, Ramji DP. Protein kinase CK2, an important regulator of the inflammatory response? J Mol Med (Berl) 2008; 86:887-97.
24. Yamaguchi Y, Wada T, Suzuki F, Takagi T, Hasegawa J, Handa H. Casein kinase II interacts with the bZIP domains of several transcription factors. Nucleic Acids Res 1998; 26:3854-61.
25. McElhinny JA, Trushin SA, Bren GD, Chester N, Paya CV. Casein kinase II phosphorylates IκBα at S-283, S-289, S-293, and T-291 and is required for its degradation. Mol Cell Biol 1996; 16:899-906.
26. Schwarz EM, Van Antwerp D, Verma IM. Constitutive phosphorylation of IκBα by casein kinase II occurs preferentially at serine 293: requirement for degradation of free IκBα. Mol Cell Biol 1996; 16:3554-9.
27. Shen J, Channavajhala P, Seldin DC, Sonenshein GE. Phosphorylation by the protein kinase CK2 promotes calpain-mediated degradation of IκBα. J Immunol 2001; 167:4919-25.
28. Kato T Jr, Delhase M, Hoffmann A, Karin M. CK2 Is a C-Terminal IκB Kinase Responsible for NF-κB Activation during the UV Response. Mol Cell 2003; 12:829-39.
29. Wang D, Westerheide SD, Hanson JL, Baldwin AS Jr. Tumor necrosis factor α-induced phosphorylation of RelA/p65 on Ser529 is controlled by casein kinase II. J Biol Chem 2000; 275:32592-7.
30. Kang NI, Yoon HY, Kim HA et al. Protein kinase CK2/PTEN pathway plays a key role in platelet-activating factor-mediated murine anaphylactic shock. J Immunol 2011; 186:6625-32.
31. Choi JH, Chung WJ, Han SJ et al. Selective involvement of reactive oxygen intermediates in platelet-activating factor-mediated activation of NF-κB. Inflammation 2000; 24:385-98.
32. Chanez P, Dent G, Yukawa T, Barnes PJ, Chung KF. Generation of oxygen free radicals from blood eosinophils from asthma patients after stimulation with PAF or phorbol ester. Eur Respir J 1990; 3:1002-7.
33. Hartung HP, Parnham MJ, Winkelmann J, Englberger W, Hadding U. Platelet activating factor (PAF) induces the oxidative burst in macrophages. Int J Immunopharmacol 1983; 5:115-21.
34. Kato M, Tokuyama K, Morikawa A, Kuroume T, Barnes PJ. Platelet-activating factor-induced enhancement of superoxide anion generation in guinea-pigs. Eur J Pharmacol 1993; 232:7-12.
35. Chiarugi P, Fiaschi T. Redox signalling in anchorage-dependent cell growth. Cell Signal 2007; 19:672-82.
36. Sayed M, Kim SO, Salh BS, Issinger OG, Pelech SL. Stress-induced activation of protein kinase CK2 by direct interaction with p38 mitogen-activated protein kinase. J Biol Chem 2000; 275:16569-73.
37. Brewster JL, de Valoir T, Dwyer ND, Winter E, Gustin MC. An osmosensing signal transduction pathway in yeast. Science 1993; 259:1760-3.
38. Thannickal VJ, Fanburg BL. Reactive oxygen species in cell signaling. Am J Physiol Lung Cell Mol Physiol 2000; 279:L1005-28.
39. Ushio-Fukai M, Alexander RW, Akers M, Griendling KK. p38 Mitogen-activated protein kinase is a critical component of the redox-sensitive signaling pathways activated by angiotensin. II Role in vascular smooth muscle cell hypertrophy. J Biol Chem 1998; 273:15022-9.
40. Han SJ, Choi JH, Ko HM, Yang HW, Choi IW, Lee HK, Lee OH, Im SY. Glucocorticoids prevent NF-κB activation by inhibiting the early release of platelet-activating factor in response to lipopolysaccharide. Eur J Immunol 1999; 29:1334-41.
41. Kravchenko VV, Pan Z, Han J, Herbert JM, Ulevitch RJ, Ye RD. Platelet-activating factor induces NF-κB activation through a G protein-coupled pathway. J Biol Chem 1995; 270:14928-34.
42. Roth M, Nauck M, Yousefi S, Tamm M, Blaser K, Perruchoud AP, Simon HU. Platelet-activating factor exerts mitogenic activity and stimulates expression of interleukin 6 and interleukin 8 in human lung fibroblasts via binding to its functional receptor. J Exp Med 1996; 184:191-201.
43. Kweon SM, Wang B, Rixter D et al. Synergistic activation of NF-κB by nontypeable H. influenzae and S. pneumoniae is mediated by CK2, IKKβ-IκBα, and p38 MAPK. Biochem Biophys Res Commun 2006; 351:368-75.
44. Litchfield DW, Luscher B, Lozeman FJ, Eisenman RN, Krebs EG. Phosphorylation of casein kinase II by p34cdc2 in vitro and at mitosis. J Biol Chem 1992; 267:13943-51.
45. Bosc DG, Slominski E, Sichler C, Litchfield DW. Phosphorylation of casein kinase II by p34cdc2. Identification of phosphorylation sites using phosphorylation site mutants in vitro. J Biol Chem 1995; 270:25872-8.
46. Munstermann U, Fritz G, Seitz G, Lu YP, Schneider HR, Issinger OG. Casein kinase II is elevated in solid human tumours and rapidly proliferating non-neoplastic tissue. Eur J Biochem 1990; 189:251-7.
47. Scaglioni PP, Yung TM, Cai LF et al. A CK2-dependent mechanism for degradation of the PML tumor suppressor. Cell 2006; 126:269-83.
48. Zhang P, Davis AT, Ahmed K. Mechanism of protein kinase CK2 association with nuclear matrix: role of disulfide bond formation. J Cell Biochem 1998; 69:211-20.
49. Jones DP. Redefining oxidative stress. Antioxid Redox Signal 2006; 8:1865-79.